IBT
CRBU icon

International Biotechnology Trust’s Caribou Biosciences CRBU Stock Holding History

International Biotechnology Trust’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-457,892
Closed -$2.43M – 67
2023
Q1 		$2.43M Buy
457,892
+200,000
+78% +$1.25M 0.68% 37
2022
Q4 		$1.62M Hold
257,892
– – 0.5% 39
2022
Q3 		$2.72M Buy
257,892
+256,514
+18,615% +$2.39M 0.87% 34
2022
Q2 		$255K Buy
+1,378
New +$10.5K 2.66% 14

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

International Biotechnology Trust's CRBU Position: Q2 2023 in Review

International Biotechnology Trust sold out of Caribou Biosciences (CRBU) in Q2 2023, closing a stake of 457,892 shares — an estimated $2.43M sold.

International Biotechnology Trust first reported a position in CRBU in Q2 2022 and held it in 4 quarters. The position peaked at $2.72M in Q3 2022. 120 funds tracked by Wall St. Rank hold CRBU as of Q2 2023.

  • International Biotechnology Trust reported no remaining Caribou Biosciences position as of Q2 2023 after selling out during the quarter.
  • International Biotechnology Trust sold 457,892 Caribou Biosciences shares in Q2 2023, an estimated $2.43M.
  • International Biotechnology Trust first reported a position in Caribou Biosciences in Q2 2022 and held it in 4 quarters.
  • International Biotechnology Trust's Caribou Biosciences position peaked at $2.72M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2023.

Based on International Biotechnology Trust's 13F filing for Q2 2023, filed 8 Aug 2023.